Trials / Completed
CompletedNCT00655889
Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Castle Creek Biosciences, LLC. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM in subjects with maxillary lesions who were treated in a previous study (IT-G-002, no NCT identification number)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Human Fibroblasts (azficel-T) | 1. Collection of biopsy from palate 2. Papillary priming procedure 3. Seven injection treatments to target sites 4. Performance of study assessments (investigator and subject) |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-04-01
- Completion
- 2008-07-01
- First posted
- 2008-04-10
- Last updated
- 2021-03-23
- Results posted
- 2013-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00655889. Inclusion in this directory is not an endorsement.